Latest Morning Briefing Stories
US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus
The government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S. under its current approach.
Prevención del VIH: proponen que Medicare cubra PrEP para adultos mayores
Según el plan de la administración Biden, Medicare cubriría el costo total de los medicamentos de profilaxis previa a la exposición, que previenen la transmisión del VIH.
Nueva ley de California ofrece protección contra facturas por viajes en ambulancia
En California, casi tres cuartas partes de los traslados de emergencia en ambulancia generan facturas fuera de la red. La factura sorpresa promedio es de $1,209, la más alta del país
New California Law Offers Fresh Protection From Steep Ambulance Bills
The law, which takes effect Jan. 1, prohibits out-of-network ground ambulance operators from billing patients more than they would pay for in-network rides. It also caps how much the uninsured must pay.
Children Who Survive Shootings Endure Huge Health Obstacles and Costs
A new study finds that young people who have been injured by firearms are more prone to psychiatric diagnoses and developing a substance use disorder than kids who have not been shot — and their families also suffer long-term ill effects.
Medicare amplía su lista de profesionales de salud mental
Los prejuicios sobre las afecciones mentales y la discriminación por edad hacen que algunos profesionales no tomen en serio el sufrimiento de las personas mayores, profundizando las barreras de acceso a la atención.
Medicare Expands the Roster of Available Mental Health Professionals
Medicare is expanding access to mental health counselors and marriage and family therapists come Jan. 1. But the belief that seniors who suffer from mental health problems should just grin and bear it remains a troubling barrier to care.
Biden Pick to Lead Social Security Pledges Action on ‘Heartbreaking’ Clawbacks
At a Senate confirmation hearing, former Maryland Gov. Martin O’Malley said he would address hardships the Social Security agency has caused by demanding money back from beneficiaries.
KFF Health News' 'What the Health?': For ACA Plans, It’s Time to Shop Around
It’s Obamacare open enrollment season, which means that, for people who rely on these plans for coverage, it’s time to shop around. With enhanced premium subsidies and cost-sharing assistance, consumers may find savings by switching plans. It is especially important for people who lost their coverage because of the Medicaid unwinding to investigate their options. Many qualify for assistance. Meanwhile, the countdown to Election Day is on, and Ohio’s State Issue 1 is grabbing headlines. The closely watched ballot initiative has become a testing ground for abortion-related messaging, which has been rife with misinformation. This week’s panelists are Mary Agnes Carey of KFF Health News, Jessie Hellmann of CQ Roll Call, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachana Pradhan of KFF Health News.
Medical Debt Is Disappearing From Americans’ Credit Reports, Lifting Scores
As credit rating agencies have removed small unpaid medical bills from consumer credit, scores have gone up, a new study finds.
Comienza la inscripción para los seguros de salud del Obamacare
Los consumidores pueden ir en línea, llamar o buscar ayuda de un corredor, o un navegador, para conocer sus opciones de cobertura para 2024, calcular sus posibles subsidios o cambiar de plan.
Medical Debt and Nurse Shortages Haunt Winning Halloween Haikus
Entries for our fifth annual Halloween haiku contest left us terrified. Based on a review by our panel of judges, here’s the winner and runners-up — plus the original artwork they inspired.
Start Shopping: Enrollment Begins Nov. 1 for Most Obamacare Insurance Plans
More than 16 million Americans who buy their own health insurance through state and federal marketplaces have until Jan. 15 to compare prices, change their coverage, or enroll for the first time.
An Arm and a Leg: John Green vs. Johnson & Johnson (Part 2)
The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of “An Arm and a Leg,” hear how a decades-long global fight to reform drug patents is helping to lower the cost.
When That Supposedly Free Annual Physical Generates a Bill
Completing a routine depression screening questionnaire during an annual checkup is cost-free under federal law. But, as one woman discovered, answering a doctor’s follow-up questions might not be.
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
Tiny, Rural Hospitals Feel the Pinch as Medicare Advantage Plans Grow
More than half of seniors are enrolled in private Medicare Advantage plans instead of traditional Medicare. Rural enrollment has increased fourfold and many small-town hospitals say that threatens their viability.
Quick Genetic Test Offers Hope for Sick, Undiagnosed Kids. But Few Insurers Offer to Pay.
A new, rapid genetic test shows promise in increasing diagnoses and improving treatment for some children with rare genetic conditions. Many insurers won’t cover it, but Florida’s Medicaid program is among those that see benefits — and, potentially, savings.
Pruebas genéticas rápidas a bebés pueden salvar vidas, pero muchas aseguradoras no las cubren
Que Medicaid cubra la prueba puede expandir significativamente el acceso para los bebés; el programa de salud federal gerenciado por los estados que asegura a las familias de bajos ingresos y que cubre a más del 40% de los niños en su primer año de vida.
Biden Pick to Lead NIH Finally Has Her Day, but Still Gets Caught Up in Drug Price Debate
Monica Bertagnolli, the president’s choice to head the National Institutes of Health, appeared before a Senate committee this week. Her confirmation has been held up by Sen. Bernie Sanders (I-Vt.), who has demanded President Joe Biden work more aggressively to lower prescription drug prices.
